Range Low Price High Price Comment
30 days $56.05 $71.62 Thursday, 28th Mar 2024 EXAS stock ended at $69.06. This is 3.26% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 6.61% from a day low at $67.18 to a day high of $71.62.
90 days $56.05 $76.60
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
2024-01-17 $64.67 $65.35 $63.05 $64.07 1 505 678
2024-01-16 $66.13 $66.42 $65.22 $66.01 1 799 157
2024-01-12 $68.34 $70.25 $67.07 $67.12 1 226 420
2024-01-11 $69.59 $70.54 $68.34 $68.64 2 188 325
2024-01-10 $70.37 $70.46 $69.15 $70.11 1 680 980
2024-01-09 $69.14 $70.03 $68.01 $69.58 1 906 637
2024-01-08 $70.50 $70.72 $67.14 $70.57 3 349 685
2024-01-05 $70.24 $73.67 $70.13 $73.20 1 957 649
2024-01-04 $69.29 $71.85 $69.01 $71.23 1 767 247
2024-01-03 $72.17 $72.36 $69.33 $69.94 1 708 696
2024-01-02 $73.50 $76.60 $73.32 $73.77 1 234 997
2023-12-29 $75.60 $76.18 $73.31 $73.98 985 534
2023-12-28 $75.31 $76.82 $75.16 $75.72 1 169 179
2023-12-27 $76.00 $77.42 $75.13 $75.68 1 240 005
2023-12-26 $74.66 $76.12 $73.87 $75.65 1 240 493
2023-12-22 $71.97 $74.71 $71.43 $73.51 2 552 595
2023-12-21 $68.50 $71.64 $68.50 $71.43 1 913 371
2023-12-20 $73.80 $76.80 $67.25 $67.30 3 520 931
2023-12-19 $65.48 $71.00 $65.11 $69.43 3 111 445
2023-12-18 $66.32 $66.82 $64.18 $64.60 2 017 273
2023-12-15 $68.15 $68.15 $65.35 $65.90 2 443 060
2023-12-14 $69.68 $72.13 $67.31 $67.80 2 125 361
2023-12-13 $66.11 $68.01 $63.80 $67.71 1 719 717
2023-12-12 $65.22 $65.55 $62.62 $65.52 2 329 122
2023-12-11 $64.58 $65.59 $63.00 $65.06 1 643 246
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT